Earlier intervention in type 2 diabetes: The case for achieving early and sustained glycaemic control

Clifford Bailey, S Del Prato, D Eddy, B Zinman

Research output: Contribution to journalArticle

Abstract

In type 2 diabetes, the onset and progression of complications is significantly delayed by improving glycaemic control. However, the proportion of patients reaching and sustaining guideline recommendations for glycaemic targets remains unacceptably low. Recent clinical trials and predictive physiologically based mathematical simulations (Archimedes model) indicate that benefits can be enhanced with earlier intervention and timely achievement of glycaemic targets. This article reviews the evidence for early intervention, showing that intensive approaches, including earlier introduction of combination therapy, allow more patients to achieve glycaemic targets and hence reduce complications and delay disease progression. © Blackwell Publishing Ltd, 2005.

Original languageEnglish
Pages (from-to)1309-1316
Number of pages8
JournalInternational Journal of Clinical Practice
Volume59
Issue number11
Early online date12 Oct 2005
DOIs
Publication statusPublished - Nov 2005

Fingerprint

Type 2 Diabetes Mellitus
Disease Progression
Clinical Trials
Guidelines
Therapeutics

Keywords

  • archimedes model
  • combination therapy
  • early intervention
  • glycaemic control
  • type 2 diabetes

Cite this

@article{4b8cf63eb3ec4a3a9bbc63b6e14cbcc3,
title = "Earlier intervention in type 2 diabetes: The case for achieving early and sustained glycaemic control",
abstract = "In type 2 diabetes, the onset and progression of complications is significantly delayed by improving glycaemic control. However, the proportion of patients reaching and sustaining guideline recommendations for glycaemic targets remains unacceptably low. Recent clinical trials and predictive physiologically based mathematical simulations (Archimedes model) indicate that benefits can be enhanced with earlier intervention and timely achievement of glycaemic targets. This article reviews the evidence for early intervention, showing that intensive approaches, including earlier introduction of combination therapy, allow more patients to achieve glycaemic targets and hence reduce complications and delay disease progression. {\circledC} Blackwell Publishing Ltd, 2005.",
keywords = "archimedes model, combination therapy, early intervention, glycaemic control, type 2 diabetes",
author = "Clifford Bailey and {Del Prato}, S and D Eddy and B Zinman",
year = "2005",
month = "11",
doi = "10.1111/j.1742-1241.2005.00675.x",
language = "English",
volume = "59",
pages = "1309--1316",
journal = "International Journal of Clinical Practice",
issn = "1368-5031",
publisher = "Wiley-Blackwell",
number = "11",

}

Earlier intervention in type 2 diabetes : The case for achieving early and sustained glycaemic control. / Bailey, Clifford; Del Prato, S; Eddy, D; Zinman, B.

In: International Journal of Clinical Practice, Vol. 59, No. 11, 11.2005, p. 1309-1316.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Earlier intervention in type 2 diabetes

T2 - The case for achieving early and sustained glycaemic control

AU - Bailey, Clifford

AU - Del Prato, S

AU - Eddy, D

AU - Zinman, B

PY - 2005/11

Y1 - 2005/11

N2 - In type 2 diabetes, the onset and progression of complications is significantly delayed by improving glycaemic control. However, the proportion of patients reaching and sustaining guideline recommendations for glycaemic targets remains unacceptably low. Recent clinical trials and predictive physiologically based mathematical simulations (Archimedes model) indicate that benefits can be enhanced with earlier intervention and timely achievement of glycaemic targets. This article reviews the evidence for early intervention, showing that intensive approaches, including earlier introduction of combination therapy, allow more patients to achieve glycaemic targets and hence reduce complications and delay disease progression. © Blackwell Publishing Ltd, 2005.

AB - In type 2 diabetes, the onset and progression of complications is significantly delayed by improving glycaemic control. However, the proportion of patients reaching and sustaining guideline recommendations for glycaemic targets remains unacceptably low. Recent clinical trials and predictive physiologically based mathematical simulations (Archimedes model) indicate that benefits can be enhanced with earlier intervention and timely achievement of glycaemic targets. This article reviews the evidence for early intervention, showing that intensive approaches, including earlier introduction of combination therapy, allow more patients to achieve glycaemic targets and hence reduce complications and delay disease progression. © Blackwell Publishing Ltd, 2005.

KW - archimedes model

KW - combination therapy

KW - early intervention

KW - glycaemic control

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=33644874319&partnerID=8YFLogxK

U2 - 10.1111/j.1742-1241.2005.00675.x

DO - 10.1111/j.1742-1241.2005.00675.x

M3 - Article

C2 - 16236086

VL - 59

SP - 1309

EP - 1316

JO - International Journal of Clinical Practice

JF - International Journal of Clinical Practice

SN - 1368-5031

IS - 11

ER -